Insys Therapeutics, Inc. Debt to Equity Ratio 2013-2019 | INSYQ
Current and historical debt to equity ratio values for Insys Therapeutics, Inc. (INSYQ) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Insys Therapeutics, Inc. debt/equity for the three months ending March 31, 2019 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2019-03-31 | $0.34B | $-0.16B | -2.05 |
| 2018-12-31 | $0.24B | $-0.04B | -5.47 |
| 2018-09-30 | $0.22B | $0.00B | 1575.02 |
| 2018-06-30 | $0.21B | $0.03B | 8.54 |
| 2018-03-31 | $0.21B | $0.05B | 4.36 |
| 2017-12-31 | $0.21B | $0.07B | 3.22 |
| 2017-09-30 | $0.22B | $0.11B | 2.05 |
| 2017-06-30 | $0.07B | $0.27B | 0.27 |
| 2017-03-31 | $0.07B | $0.27B | 0.26 |
| 2016-12-31 | $0.09B | $0.27B | 0.32 |
| 2016-09-30 | $0.09B | $0.27B | 0.32 |
| 2016-06-30 | $0.08B | $0.26B | 0.31 |
| 2016-03-31 | $0.08B | $0.25B | 0.32 |
| 2015-12-31 | $0.10B | $0.25B | 0.39 |
| 2015-09-30 | $0.08B | $0.23B | 0.35 |
| 2015-06-30 | $0.07B | $0.20B | 0.37 |
| 2015-03-31 | $0.07B | $0.18B | 0.38 |
| 2014-12-31 | $0.05B | $0.17B | 0.30 |
| 2014-09-30 | $0.04B | $0.15B | 0.30 |
| 2014-06-30 | $0.03B | $0.12B | 0.23 |
| 2014-03-31 | $0.03B | $0.10B | 0.26 |
| 2013-12-31 | $0.02B | $0.08B | 0.27 |
| 2013-09-30 | $0.02B | $0.05B | 0.39 |
| 2013-06-30 | $0.02B | $0.03B | 0.43 |
| 2013-03-31 | $0.09B | $-0.06B | -1.35 |
| 2012-12-31 | $0.08B | $-0.07B | -1.29 |
| 2012-09-30 | $0.00B | 0.00 | |
| 2012-06-30 | $0.00B | 0.00 | |
| 2012-03-31 | $0.00B | 0.00 | |
